A detailed history of Ramsay, Stattman, Vela & Price, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Ramsay, Stattman, Vela & Price, Inc. holds 104,749 shares of ABT stock, worth $12.1 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares
104,749
Previous 106,734 1.86%
Holding current value
$12.1 Million
Previous $11.1 Million 7.68%
% of portfolio
2.28%
Previous 2.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$100.07 - $118.13 $198,638 - $234,488
-1,985 Reduced 1.86%
104,749 $11.9 Million
Q2 2024

Jul 31, 2024

SELL
$100.73 - $112.44 $37,673 - $42,052
-374 Reduced 0.35%
106,734 $11.1 Million
Q1 2024

May 01, 2024

SELL
$109.52 - $120.96 $225,720 - $249,298
-2,061 Reduced 1.89%
107,108 $12.2 Million
Q4 2023

Feb 01, 2024

SELL
$90.19 - $110.4 $157,020 - $192,206
-1,741 Reduced 1.57%
109,169 $12 Million
Q3 2023

Oct 27, 2023

SELL
$95.53 - $114.62 $166,508 - $199,782
-1,743 Reduced 1.55%
110,910 $10.7 Million
Q2 2023

Jul 31, 2023

SELL
$100.78 - $112.29 $68,933 - $76,806
-684 Reduced 0.6%
112,653 $12.3 Million
Q1 2023

Apr 28, 2023

BUY
$96.86 - $114.01 $67,802 - $79,807
700 Added 0.62%
113,337 $11.5 Million
Q4 2022

Feb 03, 2023

SELL
$95.06 - $111.52 $60,838 - $71,372
-640 Reduced 0.56%
112,637 $12.4 Million
Q3 2022

Oct 28, 2022

SELL
$96.76 - $112.03 $37,542 - $43,467
-388 Reduced 0.34%
113,277 $11 Million
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $44,604 - $53,912
437 Added 0.39%
113,665 $12.4 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $5,244 - $6,395
-46 Reduced 0.04%
113,228 $13.4 Million
Q4 2021

Jan 24, 2022

SELL
$115.53 - $141.46 $69,433 - $85,017
-601 Reduced 0.53%
113,274 $15.9 Million
Q3 2021

Oct 29, 2021

SELL
$116.66 - $129.06 $49,463 - $54,721
-424 Reduced 0.37%
113,875 $13.5 Million
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $271,351 - $319,419
-2,565 Reduced 2.19%
114,299 $13.3 Million
Q1 2021

Apr 22, 2021

SELL
$108.84 - $128.23 $41,359 - $48,727
-380 Reduced 0.32%
116,864 $14 Million
Q4 2020

Jan 26, 2021

SELL
$105.0 - $114.42 $198,450 - $216,253
-1,890 Reduced 1.59%
117,244 $12.8 Million
Q3 2020

Nov 09, 2020

BUY
$91.64 - $111.29 $32,532 - $39,507
355 Added 0.3%
119,134 $13 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $323,508 - $414,050
-4,225 Reduced 3.43%
118,779 $10.9 Million
Q1 2020

May 04, 2020

SELL
$62.82 - $91.86 $67,217 - $98,290
-1,070 Reduced 0.86%
123,004 $9.71 Million
Q4 2019

Jan 28, 2020

BUY
$78.51 - $87.4 $24,887 - $27,705
317 Added 0.26%
124,074 $10.8 Million
Q3 2019

Nov 07, 2019

SELL
$81.84 - $88.74 $149,112 - $161,684
-1,822 Reduced 1.45%
123,757 $10.4 Million
Q2 2019

Aug 09, 2019

SELL
$72.88 - $85.0 $267,834 - $312,375
-3,675 Reduced 2.84%
125,579 $10.6 Million
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $144,359 - $174,530
-2,180 Reduced 1.66%
129,254 $10.3 Million
Q4 2018

Feb 05, 2019

SELL
$65.56 - $74.27 $262,895 - $297,822
-4,010 Reduced 2.96%
131,434 $9.51 Million
Q3 2018

Oct 30, 2018

SELL
$60.81 - $73.36 $60,810 - $73,360
-1,000 Reduced 0.73%
135,444 $9.94 Million
Q2 2018

Aug 01, 2018

SELL
$57.57 - $63.54 $29,936 - $33,040
-520 Reduced 0.38%
136,444 $8.32 Million
Q1 2018

May 01, 2018

BUY
$56.27 - $63.62 $22,226 - $25,129
395 Added 0.29%
136,964 $8.21 Million
Q4 2017

Jan 30, 2018

SELL
$53.68 - $57.47 $128,724 - $137,813
-2,398 Reduced 1.73%
136,569 $7.79 Million
Q3 2017

Oct 30, 2017

BUY
$48.06 - $53.64 $79,395 - $88,613
1,652 Added 1.2%
138,967 $7.42 Million
Q2 2017

Aug 07, 2017

BUY
N/A
137,315
137,315 $6.68 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ramsay, Stattman, Vela & Price, Inc. Portfolio

Follow Ramsay, Stattman, Vela & Price, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ramsay, Stattman, Vela & Price, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ramsay, Stattman, Vela & Price, Inc. with notifications on news.